Latest news
-
Avalyn Pharma announces appointments of Adam Golden as Head of Business Development and Frank Salisbury as Senior VP, Commercial
Inhaled drug developer Avalyn Pharma has announced the appointments of attorney Adam Golden as General Counsel and Head of Business Development and pharma sales and marketing veteran Frank Salisbury as Senior VP, Commercial. Golden was… [Read more . . .]
-
FDA approves Cipla’s generic of Ventolin HFA albuterol MDI
Cipla has received FDA approval of its ANDA for a generic version of Ventolin HFA albuterol MDI for the treatment of asthma, the company announced. GSK’s NDA Ventolin HFA was approved by the agency in… [Read more . . .]
-
Rocket Science Health gets additional US patent covering its nasal delivery technology
Rocket Science Health announced that the United States Patent and Trademark Office (USPTO) has issued US Patent No. 12,569,658, titled “Dual Nozzles For Insertion Into Paired Body Orifices (e.g., Nasal Passages, Etc.)” covering the company’s intranasal… [Read more . . .]
-
Vistagen gets go-ahead for Phase 2 trial of refisolone (PH-80) nasal spray for the treatment of hot flashes
Vistagen announced that it has received a “study may proceed” letter from the FDA in response to the company’s IND for a Phase 2 trial of refisolone nasal spray for the treatment of hot flashes caused… [Read more . . .]
-
FDA extends review of Savara’s BLA for Molbreevi molgramostim inhalation solution for the treatment of aPAP
Savara has announced that the FDA is giving itself extra time to review the company’s BLA for molgramostim inhalation solution for the treatment of autoimmune pulmonary alveolar proteinosis, setting November 22, 2026 as the new… [Read more . . .]
Other recent news
-
ARS Pharma and ALK announce that Health Canada has approved neffy epinephrine nasal spray
-
Amneal launches generic versions of ProAir HFA albuterol MDI and QVAR beclomethasone MDI in the US
-
Iconovo names Anders Månsson as permanent CEO
-
Oragenics initiates Phase 2a trial of ONP-002 neurosteroid nasal powder for mild TBI
-
Nemera to offer Therakind’s DriDose intranasal dry powder nasal device
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
May 10-May 14: RDD 2026, Phoenix, AZ, USA
May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA
May 17-May 20: ATS International Conference 2026, Orlando, FL, USA
June 9-June 10: Nasal Drug Delivery Symposium: Current Status and Future Opportunities, Stockholm, Sweden
June 10: SMI.London 2026, London, UK